Scientists have shown in mice that skin cells re-programmed into brain stem cells, transplanted into the central nervous system, help reduce inflammation and may be able to help repair damage caused by multiple sclerosis (MS).
Our mouse study suggests that using a patient’s reprogrammed cells could provide a route to personalised treatment of chronic inflammatory diseases, including progressive forms of MS
The study, led by researchers at the University of Cambridge, is a step towards developing personalised treatments based on a patient’s own skin cells for diseases of the central nervous system (CNS).
In MS, the body’s own immune system attacks and damages myelin, the protective sheath around nerve fibres, causing disruption to messages sent around the brain and spinal cord. Symptoms are unpredictable and include problems with mobility and balance, pain, and severe fatigue.
Key immune cells involved in causing this damage are macrophages (literally ‘big eaters’), which ordinarily serve to attack and rid the body of unwanted intruders. A particular type of macrophage known as microglia are found throughout the brain and spinal cord – in progressive forms of MS, they attack the CNS, causing chronic inflammation and damage to nerve cells.
Recent advances have raised expectations that diseases of the CNS may be improved by the use of stem cell therapies. Stem cells are the body’s ‘master cells’, which can develop into almost any type of cell within the body. Previous work from the Cambridge team has shown that transplanting neural stem cells (NSCs) – stem cells that are part-way to developing into nerve cells – reduces inflammation and can help the injured CNS heal.
However, even if such a therapy could be developed, it would be hindered by the fact that such NSCs are sourced from embryos and therefore cannot be obtained in large enough quantities. Also, there is a risk that the body will see them as an alien invader, triggering an immune response to destroy them.
A possible solution to this problem would be the use of so-called ‘induced neural stem cells (iNSCs)’ – these cells can be generated by taking an adult’s skin cells and ‘re-programming’ them back to become neural stem cells. As these iNSCs would be the patient’s own, they are less likely to trigger an immune response.
Now, in research published in the journal Cell Stem Cell, researchers at the University of Cambridge have shown that iNSCs may be a viable option to repairing some of the damage caused by MS.
Using mice that had been manipulated to develop MS, the researchers discovered that chronic MS leads to significantly increased levels of succinate, a small metabolite that sends signals to macrophages and microglia, tricking them into causing inflammation, but only in cerebrospinal fluid, not in the peripheral blood.
Transplanting NSCs and iNSCs directly into the cerebrospinal fluid reduces the amount of succinate, reprogramming the macrophages and microglia – in essence, turning ‘bad’ immune cells ‘good’. This leads to a decrease in inflammation and subsequent secondary damage to the brain and spinal cord.
“Our mouse study suggests that using a patient’s reprogrammed cells could provide a route to personalised treatment of chronic inflammatory diseases, including progressive forms of MS,” says Dr Stefano Pluchino, lead author of the study from the Department of Clinical Neurosciences at the University of Cambridge.
“This is particularly promising as these cells should be more readily obtainable than conventional neural stem cells and would not carry the risk of an adverse immune response.”
The research team was led by Dr Pluchino, together with Dr Christian Frezza from the MRC Cancer Unit at the University of Cambridge, and brought together researchers from several university departments.
Dr Luca Peruzzotti-Jametti, the first author of the study and a Wellcome Trust Research Training Fellow, says: “We made this discovery by bringing together researchers from diverse fields including regenerative medicine, cancer, mitochondrial biology, inflammation and stroke and cellular reprogramming. Without this multidisciplinary collaboration, many of these insights would not have been possible.”
The Latest on: Personalised stem cell treatment
Scientists uncover DNA 'shield' w/crucial roles in normal cell division
on July 18, 2018 at 11:21 am
In immune cells, this is crucial to make antibodies In cancer ... Today it is a world leader at identifying cancer-related genes and discovering new targeted drugs for personalised cancer treatment. A ... […]
Cancer Scientists Have Ignored African DNA in the Search for Cures
on July 18, 2018 at 6:01 am
Following that breakthrough, scientists in six countries across the globe had begun collecting blood samples to find genes responsible for various conditions, including serious diseases, which could l... […]
Cancer DNA treatment program expanded
on July 17, 2018 at 3:43 pm
Mr Hunt said the world-leading treatment means each patient gets treated for their own individual cancer in their own home state or territory. The program works by looking deep into each patient's can... […]
Scientists Have Discovered A New Gene-editing Technique That Could Mean Major Advances In Cancer Treatment
on July 13, 2018 at 8:34 am
In the meantime, scientists are seeking approval from the U.S. Food and Drug Administration to use the repaired T cells to treat the three children. It may take a while before this gene-editing techno... […]
Genetic tool evaluates breast cancer patient's treatment
on July 12, 2018 at 11:08 pm
Such cancer is often treated with hormone therapy, although chemotherapy can be used as well. In this trial, the authors gauged the need for chemotherapy based on a genetic tool called the 21-gene bre... […]
Swift Gene-Editing Method May Revolutionize Treatments for Cancer and Infectious Diseases
on July 12, 2018 at 6:33 am
A colored scanning electron micrograph of a white blood cell amid red blood cells. Researchers hope a new method to boost immune systems could make a treatment available to patients with almost any ty... […]
See-Through Fish Could Reveal Origins of Neuroblastoma
on July 11, 2018 at 3:20 am
Finding the “off” switch for SOX10 in neural crest cells could potentially lead to treatments for cancers where SOX proteins ... At the Forefront of Personalised Medicine Development Finally, zebrafis... […]
How combining ultrasound, gene therapy and drugs switches neurons on and off
on July 10, 2018 at 1:16 am
With the Red Sea parted, the second phase of the treatment can get into the brain to do its work. The team has engineered viruses that carry genetic instructions to specific cells. Once there, they co... […]
Biologics Market During 2018-2023 to Gain Robust Traction By Type; Vaccines, Blood Products, Proteins, Gene Therapy and Others
on July 9, 2018 at 3:47 am
Growing approval of medicines that are patient centric and personalized have added further impetus to ... blood products, gene therapy and other. Vaccines are additionally sub segmented into attenuate... […]
'Cancer Is Almost Always a Crisis'
on July 5, 2018 at 4:25 pm
Ultimately, Greer believes that mobile technologies will form "just one more layer of support" for patients, in a fashion similar to the support offered through personalized care to patients undergoin... […]
via Google News and Bing News